< Back | |
01 Feb 2016 | |
The Exchange has sought clarification from Aurobindo Pharma Ltd today with reference to news displayed - in MONEYCONTROL on February 01, 2016 : "unit 3 and unit 7 inspected USFDA,UNIT 7 sees few observations" <BR><BR>The reply is awaited. | |
View all announcements for AUROBINDO PHARMA LTD. | Source: BSE India |